Loading Events

« All Events

  • This event has passed.

Israel COVID-19 Vaccine Developments WEBINAR

May 6 @ 12:00 PM - 1:00 PM

The world awaits a COVID-19 cure. Learn how Israel has mobilized its scientific and technological talents to overcome this modern-day plague, featuring:

  • Yaky Yanai, CEO of Pluristem Therapeutics (NASDAQ: PSTI) is working on a placenta-based cell therapy treatment for respiratory and inflammatory complications associated with COVID-19.
  • Vered Kaplan, CEO of Orgenesis, (NASDAQ: ORGS) a global biotech company, is unlocking the potential of cell and gene therapy including anti-viral technologies relevant for COVID-19 to provide life changing personalized medical treatments at the point-of-care to patients.
  • Dr. Mark Levitt, Medical Director from RedHill Biopharma (Nasdaq: RDHL) a specialty biopharmaceutical company, is working on an experimental drug, Opaganib, which has shown anti-viral and anti-inflammatory properties to help reduce lung inflammation in COVID-19 patients.

Zoom information will be given upon registration. For more information contact, bbogage@marylandisrael.org.

Sponsored by the Maryland/Israel Development Center

Details

Date:
May 6
Time:
12:00 PM - 1:00 PM
Event Category:
Website:
https://ventures.jhu.edu/event/israel-covid-19-vaccine-developments-webinar/

Venue

Webinar
Maryland United States
Website:
https://ventures.jhu.edu/venue/webinar/

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.